Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

1.5%

6 terminated/withdrawn out of 412 trials

Success Rate

92.9%

+6.4% vs industry average

Late-Stage Pipeline

16%

67 trials in Phase 3/4

Results Transparency

1%

1 of 78 completed trials have results

Key Signals

84 recruiting1 with results4 withdrawn

Enrollment Performance

Analytics

N/A
131(46.8%)
Phase 2
71(25.4%)
Phase 3
37(13.2%)
Phase 4
30(10.7%)
Phase 1
10(3.6%)
Early Phase 1
1(0.4%)
280Total
N/A(131)
Phase 2(71)
Phase 3(37)
Phase 4(30)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (412)

Showing 20 of 412 trials
NCT07533825Not ApplicableEnrolling By Invitation

Laparoscopic Staging for Stage III Gastric Cancer

Role: collaborator

NCT07530276Active Not Recruiting

A Prospective Observational Study of Changes in Cortisol Levels After Neoadjuvant Immunotherapy and Their Prognostic Value in Patients With NSCLC

Role: lead

NCT07528066Recruiting

Downstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLC

Role: collaborator

NCT07529028Not ApplicableNot Yet Recruiting

Safety and Efficacy of the AbsnowTM II Absorbable Atrial Septal Defect Closure System for Atrial Septal Defect Closure Therapy

Role: collaborator

NCT07521605Phase 2Not Yet Recruiting

Short-Course Radiotherapy, Nal-IRI, Capecitabine, and Camrelizumab for Locally Advanced MSS Rectal Cancer

Role: lead

NCT07518251Not ApplicableRecruiting

CompaRison of FEmorofemoral Bypass and Left-Heart ByPass Techniques in Open Thoracoabdominal AortIc Aneurysm Repair

Role: collaborator

NCT04877821Phase 2Completed

The Efficacy and Safety of Sintilimab Plus Anlotinib Combined With Chemotherapy as Neoadjuvant Therapy in TNBC

Role: lead

NCT07505862Recruiting

Scientific Validity Assessment and Optimization of AI-Generated A3/A4 Type Questions for the Chinese Medical Licensing Examination

Role: lead

NCT07505667Not ApplicableRecruiting

Yiyuancong for the Treatment of Sudden Sensorineural Hearing Loss

Role: lead

NCT07495774Recruiting

Insights Into Pediatric Pulmonary Hypertension: A Real-World Registry of Epidemiology and Outcomes

Role: lead

NCT07352930Not ApplicableNot Yet Recruiting

A Novel Intraoperative Fluorescence-guided System for Evaluating Margins During Breast-conserving Surgery for Breast Cancer

Role: lead

NCT07486310Phase 2Not Yet Recruiting

Evaluation of Pressurized Intraperitoneal Aerosol Chemotherapy With VRT106 Versus PIPAC in Patients With Advanced Gastric Cancer and PeritonealMetastasis: A Prospective, Multicenter, Open-Label, Randomized Controlled Trial

Role: lead

NCT07483398Phase 4Active Not Recruiting

RELIEF-PD: Crisugabalin for Nociplastic Pain in Parkinson's Disease

Role: lead

NCT07472478Phase 2Not Yet Recruiting

Phase II Neoadjuvant Study of Garsorasib Followed by Ivonescimab Plus Chemotherapy in Resectable Stage IIA-IIIB KRAS G12C-Mutant NSCLC (GIVEN Study)

Role: lead

NCT07459296Phase 3Recruiting

Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC

Role: collaborator

NCT06933251Phase 2Active Not Recruiting

PCSK9 Inhibitor and PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy for pMMR/MSS Locally Advanced Rectal Cancer

Role: lead

NCT07447973Recruiting

Multimodal Deep Learning Model for Multi-task Diagnosis and Triage Suggestions of Ophthalmic Diseases

Role: lead

NCT07441382Not ApplicableNot Yet Recruiting

Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation

Role: lead

NCT07176182Phase 2Not Yet Recruiting

Clinical Trial of Neoadjuvant mFOLFOX Plus Alvenor for LARC Patients With High YWHAB Expression

Role: collaborator

NCT07410169Phase 2Not Yet Recruiting

Efficacy and Safety of Hyperbaric Oxygen Therapy in Improving Nab-paclitaxel-Induced Peripheral Neuropathy

Role: lead